The Gross Margin of Tasly Pharmaceutical Group Co Ltd (600535.SS) is 66.94%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 66.94% |
| 2022-12-31 | 63.37% |
| 2021-12-31 | 66.27% |
| 2020-12-31 | 40.62% |
| 2019-12-31 | 31.28% |
| 2018-12-31 | 36.19% |
| 2017-12-31 | 36.24% |
| 2016-12-31 | 36.49% |
| 2015-12-31 | 38.71% |
| 2014-12-31 | 37.41% |